Tenzing in its latest 8-K filing released an investor presentation highlighting Reviva Pharmaceuticals. A shareholder vote on the SPAC’s proposed merger with Reviva is set for Dec. 8. Read more.
Tenzing Releases Investor Presentation on Reviva
Related Posts
Aequi Underwriters to Exercise Option on $30M Stock Buy
In addition, Aequi said it expects to close the sale of an additional 400,000 private placement warrants at $1.50 each, generating $600,000.
Arago Acquisition Withdraws $75M IPO
The SPAC in its original S-1 filing said it would target “high growth target businesses that are headquartered in Latin America and are operating within sectors that have significant unmet demand.”
East Stone Acquisition Shores up JHD Merger with Backstop
The SPAC's sponsor Double Venture Holdings has twice deposited $1.38 million into the trust account for deadline extensions.
Churchill VII More Than Triples Planned Raise to $1B Ahead of IPO
The SPAC in its initial filing last month planned a $300 million raise.